Loading
Solara Active Pharma Stock: price and insider trades · India
IN·Mcap ₹31.3B
Solara Active Pharma: what insiders have been doing
Insider filings for Solara Active Pharma are scarce in the SEBI (PIT + SAST) feed, the latest one published on 30 September 2026. This page will fill in as new trades are disclosed. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 17,579 of 24,166 companies
36.4
score / 100
Value34
Quality39
FCF yld3.0%
Earn yld-0.2%
EV/EBITDA23.9x
ROE·
Gross mgn47%
Net mgn-0.6%
Debt/EBITDA4.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹648.65
Analyst consensus
Income statement
Revenue₹13.3B
Gross profit₹6.2B47% margin
EBITDA₹1.7B13% margin
Net income-₹74.1M-0.1% margin
Valuation
P/Book2.3x
Beta0.92
Balance sheet & cash
Market cap₹31.3B
Total debt₹6.9B
Free Cash Flow₹1B
Debt / Equity55%
Profitability & ownership
% insiders52.2%
% institutions16.6%
Last declaration on 30 September 2026
Declarations1 total
2,000,000 sharesEquity SharesAcquisition of shares - Encumbrance CreationSEBI:7c2e5bcc01a6ae269261aaf4ac86e7265fb17144
1 of 1 declaration
About Solara Active Pharma
Solara Active Pharma is a company specializing in the manufacture of active pharmaceutical ingredients. It is listed on the XBOM.
